Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32.
Design Therapeutics Inc. (DSGN)
Market is closed
News
- Displaying 4
Hedge Fund and Insider Trading News: TimesSquare Capital Management, Hunting Hill Global Capital, Coinbase Global Inc (COIN), Design Therapeutics, Inc. (DSGN), and More
TimesSquare Capital Management, an equity investment management company, released its “U.S. Concentrated Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: Kyle Bass, Phase 2 Partners, Viking Global Investors, Elliott Management, Oasis Management, Third Point LLC, Origo Fonder, Design Therapeutics Inc (DSGN), and More
Hayman Capital Management founder and CIO Kyle Bass joined "Mornings with Maria," Wednesday and warned that Wall Street is "funding" Russia’s war machine.
Hedge Fund and Insider Trading News: Engine No. 1, Renaissance Technologies, Glenview Capital, Morgan Creek Capital, Ree Automotive Holding Inc (REE), Xcel Energy Inc (XEL), and More
Activist firm Engine No. 1 after winning three board seats at Exxon is meeting with other oil companies in its climate change fight, a source familiar told CNBC’s David Faber.
Billionaire Hedge Funds
